Identification of 2-benzoxazolinone derivatives as lead against molecular targets of diabetic complications.
Diabetic complications follow multiple pathophysiological pathways involving aldose reductase (ALR2)-mediated polyol pathway, advanced glycation end products (AGEs) and reactive oxygen species formation. Literature suggests ALR2 inhibitors such as epalres..... Read More